Literature DB >> 26085156

Hepatitis B Virus Covalently Closed Circular DNA Formation in Immortalized Mouse Hepatocytes Associated with Nucleocapsid Destabilization.

Xiuji Cui, Ju-Tao Guo, Jianming Hu.   

Abstract

Hepatitis B virus (HBV) infects hundreds of millions of people worldwide and causes acute and chronic hepatitis, cirrhosis, and hepatocellular carcinoma. HBV is an enveloped virus with a relaxed circular (RC) DNA genome. In the nuclei of infected human hepatocytes, conversion of RC DNA from the incoming virion or cytoplasmic mature nucleocapsid (NC) to the covalently closed circular (CCC) DNA, which serves as the template for producing all viral transcripts, is essential to establish and sustain viral replication. For reasons yet to be understood, HBV is apparently unable to make CCC DNA in normal mouse hepatocytes in the liver. We report here that HBV CCC DNA was formed efficiently in an immortalized mouse hepatocyte cell line, AML12HBV10, and this is associated with destabilization of mature NCs in these cells. These results suggest that destabilization of mature HBV NCs in AML12HBV10 cells facilitates efficient NC uncoating and subsequent CCC DNA formation. They further implicate NC uncoating as an important step in CCC DNA formation that is subject to host regulation and potentially a critical determinant of host range and/or cell tropism of HBV. IMPORTANCE Persistent infection by hepatitis B virus (HBV), afflicting hundreds of millions worldwide, is sustained by the episomal viral covalently closed circular (CCC) DNA in the nuclei of infected hepatocytes. CCC DNA is converted from the viral genomic (precursor) DNA contained in cytoplasmic viral nucleocapsids. The conversion process remains ill defined, but host cell factors are thought to play an essential role. In particular, HBV fails to make CCC DNA in normal mouse hepatocytes despite the presence of large amounts of nucleocapsids containing the precursor viral DNA. We have found that in an immortalized mouse hepatocyte cell line, HBV is able to make abundant amounts of CCC DNA. This ability correlates with increased instability of viral nucleocapsids in these cells, which likely facilitates nucleocapsid disassembly (uncoating) to release the genomic DNA for conversion to CCC DNA. Our studies have thus revealed a novel mechanism of controlling viral persistence via regulating nucleocapsid disassembly.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26085156      PMCID: PMC4524059          DOI: 10.1128/JVI.01261-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Regulation of hepadnavirus reverse transcription by dynamic nucleocapsid phosphorylation.

Authors:  Suresh H Basagoudanavar; David H Perlman; Jianming Hu
Journal:  J Virol       Date:  2006-11-29       Impact factor: 5.103

2.  Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virus.

Authors:  Chunxiao Xu; Haitao Guo; Xiao-Ben Pan; Richeng Mao; Wenquan Yu; Xiaodong Xu; Lai Wei; Jinhong Chang; Timothy M Block; Ju-Tao Guo
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

3.  Lambda interferon inhibits hepatitis B and C virus replication.

Authors:  Michael D Robek; Bryan S Boyd; Francis V Chisari
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

4.  Formation of hepatitis B virus covalently closed circular DNA: removal of genome-linked protein.

Authors:  Weifan Gao; Jianming Hu
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

5.  Lambda and alpha interferons inhibit hepatitis B virus replication through a common molecular mechanism but with different in vivo activities.

Authors:  Nicole E Pagliaccetti; Esther N Chu; Christopher R Bolen; Steven H Kleinstein; Michael D Robek
Journal:  Virology       Date:  2010-03-29       Impact factor: 3.616

6.  Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G.

Authors:  David H Nguyen; Suryaram Gummuluru; Jianming Hu
Journal:  J Virol       Date:  2007-02-21       Impact factor: 5.103

7.  Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation.

Authors:  Haitao Guo; Dong Jiang; Tianlun Zhou; Andrea Cuconati; Timothy M Block; Ju-Tao Guo
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

8.  Production and function of the cytoplasmic deproteinized relaxed circular DNA of hepadnaviruses.

Authors:  Haitao Guo; Richeng Mao; Timothy M Block; Ju-Tao Guo
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

9.  Hepatitis B virus replication and release are independent of core lysine ubiquitination.

Authors:  Mayra L Garcia; Rushelle Byfield; Michael D Robek
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

10.  Requirement of heat shock protein 90 for human hepatitis B virus reverse transcriptase function.

Authors:  Jianming Hu; Dafna Flores; David Toft; Xingtai Wang; David Nguyen
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

View more
  29 in total

1.  Identification of an Intermediate in Hepatitis B Virus Covalently Closed Circular (CCC) DNA Formation and Sensitive and Selective CCC DNA Detection.

Authors:  Jun Luo; Xiuji Cui; Lu Gao; Jianming Hu
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

Review 2.  Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics.

Authors:  Ju-Tao Guo; Haitao Guo
Journal:  Antiviral Res       Date:  2015-08-10       Impact factor: 5.970

Review 3.  Host functions used by hepatitis B virus to complete its life cycle: Implications for developing host-targeting agents to treat chronic hepatitis B.

Authors:  Bidisha Mitra; Roshan J Thapa; Haitao Guo; Timothy M Block
Journal:  Antiviral Res       Date:  2018-08-24       Impact factor: 5.970

4.  Hepatitis B Virus Infection of a Mouse Hepatic Cell Line Reconstituted with Human Sodium Taurocholate Cotransporting Polypeptide.

Authors:  Florian A Lempp; Bingqian Qu; Yong-Xiang Wang; Stephan Urban
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

5.  A global scientific strategy to cure hepatitis B.

Authors:  Peter A Revill; Francis V Chisari; Joan M Block; Maura Dandri; Adam J Gehring; Haitao Guo; Jianming Hu; Anna Kramvis; Pietro Lampertico; Harry L A Janssen; Massimo Levrero; Wenhui Li; T Jake Liang; Seng-Gee Lim; Fengmin Lu; M Capucine Penicaud; John E Tavis; Robert Thimme; Fabien Zoulim
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-04-10

6.  Discovery and Mechanistic Study of Benzamide Derivatives That Modulate Hepatitis B Virus Capsid Assembly.

Authors:  Shuo Wu; Qiong Zhao; Pinghu Zhang; John Kulp; Lydia Hu; Nicky Hwang; Jiming Zhang; Timothy M Block; Xiaodong Xu; Yanming Du; Jinhong Chang; Ju-Tao Guo
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

Review 7.  Revisiting Hepatitis B Virus: Challenges of Curative Therapies.

Authors:  Jianming Hu; Ulrike Protzer; Aleem Siddiqui
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

8.  Viral DNA-Dependent Induction of Innate Immune Response to Hepatitis B Virus in Immortalized Mouse Hepatocytes.

Authors:  Xiuji Cui; Daniel N Clark; Kuancheng Liu; Xiao-Dong Xu; Ju-Tao Guo; Jianming Hu
Journal:  J Virol       Date:  2015-10-21       Impact factor: 5.103

9.  Modification of Three Amino Acids in Sodium Taurocholate Cotransporting Polypeptide Renders Mice Susceptible to Infection with Hepatitis D Virus In Vivo.

Authors:  Wenhui He; Zhiliang Cao; Fengfeng Mao; Bijie Ren; Yunfei Li; Dan Li; Huiyu Li; Bo Peng; Huan Yan; Yonghe Qi; Yinyan Sun; Fengchao Wang; Jianhua Sui; Wenhui Li
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

Review 10.  In vivo models of hepatitis B and C virus infection.

Authors:  Benjamin Y Winer; Qiang Ding; Jenna M Gaska; Alexander Ploss
Journal:  FEBS Lett       Date:  2016-04-08       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.